Nang Kuang Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	327.26	345.67	301.54	378.48	401.2	417.12
Trading Asset Securities	-	-	-	-	1.31	1.28
Cash & Short-Term Investments	327.26	345.67	301.54	378.48	402.51	418.41
Cash Growth	-9.72%	14.63%	-20.33%	-5.97%	-3.80%	56.21%
Accounts Receivable	399.12	363.56	423.08	374.67	386.71	350.44
Other Receivables	0.63	0.98	0.12	1.3	0.15	0.4
Receivables	399.75	364.54	423.2	375.97	386.86	350.84
Inventory	665.79	731.56	709.06	762.62	827.58	701.44
Prepaid Expenses	96.38	24.23	20.36	20.61	23.38	20.71
Other Current Assets	25.16	26.61	1.83	-	-	-
Total Current Assets	1,514	1,493	1,456	1,538	1,640	1,491
Property, Plant & Equipment	2,134	2,089	2,105	1,867	1,602	1,682
Long-Term Investments	127	114.81	129.12	152.18	118.97	50.29
Other Intangible Assets	5.88	5.28	4.34	5.2	3.87	5.21
Long-Term Deferred Tax Assets	28.71	25.39	22.02	39.36	27.07	29.84
Other Long-Term Assets	59	96.68	95.99	255.08	192.61	169.83
Total Assets	3,869	3,823	3,813	3,856	3,585	3,429
Accounts Payable	199.02	211.55	210.38	166.8	254.3	224.34
Accrued Expenses	-	122.32	113.99	100.61	-	-
Short-Term Debt	500	460	450	580	370	479.99
Current Portion of Long-Term Debt	10.33	8.93	19.86	12.5	12.5	12.5
Current Portion of Leases	0.19	0.37	0.75	0.49	1.05	1.26
Current Income Taxes Payable	37.35	22.64	11.78	2.7	57.01	46.61
Current Unearned Revenue	111.64	121.42	123.9	127.97	142.49	131.55
Other Current Liabilities	382.99	117.55	212.17	291.63	203.04	176.7
Total Current Liabilities	1,242	1,065	1,143	1,283	1,040	1,073
Long-Term Debt	184.49	186.39	167.26	112.5	25	37.5
Long-Term Leases	-	-	0.37	0.07	0.59	1.55
Pension & Post-Retirement Benefits	-	51.75	50.01	53.71	53	53.36
Long-Term Deferred Tax Liabilities	0.56	0.68	0.35	-	1.2	0.26
Other Long-Term Liabilities	82.41	30.1	30.1	30.1	53.33	23.06
Total Liabilities	1,509	1,334	1,391	1,479	1,174	1,189
Common Stock	1,010	1,010	1,010	1,010	1,010	1,010
Additional Paid-In Capital	164.22	245.01	325.8	426.79	457.09	482.34
Retained Earnings	1,181	1,229	1,086	940.46	944.03	748.02
Comprehensive Income & Other	-0.04	-0.04	-0.04	-0.03	0.02	-0.04
Total Common Equity	2,355	2,484	2,422	2,377	2,411	2,240
Minority Interest	5	5.53	-	-	-	-
Shareholders' Equity	2,360	2,490	2,422	2,377	2,411	2,240
Total Liabilities & Equity	3,869	3,823	3,813	3,856	3,585	3,429
Total Debt	695	655.69	638.23	705.56	409.13	532.81
Net Cash (Debt)	-367.74	-310.02	-336.69	-327.08	-6.62	-114.4
Net Cash Per Share	-3.64	-3.06	-3.33	-3.23	-0.07	-1.13
Filing Date Shares Outstanding	100.99	100.99	100.99	100.99	100.99	100.99
Total Common Shares Outstanding	100.99	100.99	100.99	100.99	100.99	100.99
Working Capital	272.83	427.82	313.17	254.99	599.94	418.44
Book Value Per Share	23.32	24.60	23.98	23.54	23.87	22.18
Tangible Book Value	2,349	2,479	2,418	2,372	2,407	2,235
Tangible Book Value Per Share	23.26	24.55	23.94	23.49	23.84	22.13
Land	-	757.96	767.41	573.57	247.28	247.28
Buildings	-	1,223	1,232	1,134	1,120	1,111
Machinery	-	2,698	2,586	2,506	2,431	2,359
Construction In Progress	-	109	56.54	26.79	36.53	41.57